KDM1A and cancer: Experimental strategies, such as the knockdown of LSD1 expression using small‐interfering RNAs, demonstrate inhibitory effects on oncogenes, reducing the growth rate, migration and invasion abilities of cancer cells while restoring therapeutic sensitivity.